ArticleInternational journal of preventive medicine2026
Food-Based Dietary Inflammatory Index in Relation to Breast Cancer.
Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is no study on the association between food-based dietary inflammatory index (FDII) and odds of breast cancer. This study was conducted to investigate the association between FDII and odds of breast cancer in Iranian women. Methods: In this population-based case-control study, we enrolled 350 pathologically confirmed new cases of breast cancer and 700 controls which were matched with cases in terms of age and socioeconomic status. FDII score was calculated based on participants' dietary intakes. Results: A significant positive association was found between FDII and odds of breast cancer (odds ratio [OR]: 1.38, 95% confidence interval [CI]: 1.01-1.88); such that after taking potential confounders into account, women in the highest tertile of FDII score were 1.52 time more likely to have breast cancer compared with those in the lowest tertile (OR: 1.52, 95% CI: 1.05-2.18). Such a significant positive association was also observed among postmenopausal women, either before (OR: 1.53, 95% CI: 1.09-2.14) or after (OR: 1.54, 95% CI: 1.05-2.27) controlling for covariates. The same association was also observed in normal-weight women, and it remained significant even after controlling for potential confounders (OR: 1.58, 95% CI: 1.04-2.41). Conclusions: We found a significant positive association between FDII and the odds of breast cancer in women, particularly postmenopausal ones.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.